Related Experiment Videos
Extraction and characterization of circulating plasma DNA from patients with pulmonary embolism
Bollettino Dell'Istituto Sieroterapico Milanese
|January 1, 1985
Abstract:
Circulating DNA has been extracted from plasma of 6 patients with pulmonary embolism; it appears of low molecular weight (about 400 base pairs) and of uniform size; its staining sensitivity to ethidium bromide suggests it is mainly double stranded. DNA circulates linked with proteins.
Insights
Circulating cell-free DNA (cfDNA) in pulmonary embolism patients is small and double-stranded. This cfDNA is bound to proteins in the bloodstream.
Area of Science:
- Biochemistry
- Molecular Biology
- Medical Diagnostics
Background:
- Pulmonary embolism (PE) is a serious condition with diagnostic challenges.
- Understanding circulating cell-free DNA (cfDNA) characteristics may offer diagnostic insights.
- Previous research on cfDNA in PE is limited.
Purpose of the Study:
- To characterize the molecular properties of cfDNA in patients with pulmonary embolism.
- To investigate the potential association of cfDNA with proteins in the plasma of PE patients.
Main Methods:
- Extraction of circulating DNA from the plasma of six pulmonary embolism patients.
- Analysis of DNA molecular weight and size uniformity.
- Ethidium bromide staining to assess DNA structure (single-stranded vs. double-stranded).
- Investigation of DNA-protein interactions.
Main Results:
- Circulating DNA extracted from PE patients had a low molecular weight, approximately 400 base pairs.
- The extracted DNA fragments were of uniform size.
- Ethidium bromide staining indicated the DNA was predominantly double-stranded.
- Evidence suggests that circulating DNA exists in complex with proteins.
Conclusions:
- Circulating DNA in pulmonary embolism patients exhibits specific characteristics: low molecular weight, uniform size, and double-stranded nature.
- DNA in circulation is associated with proteins, suggesting a complex biological role.
- Further research is warranted to explore the diagnostic and prognostic implications of these cfDNA findings in PE.